NextCure, Inc. (NXTC) Financials

NXTC Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 139.9 million 13.5 million
2023-06-30 153.4 million 15.0 million
2023-03-31 167.8 million 13.6 million
2022-12-31 184.2 million 16.6 million

NXTC Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -13.1 million 2.0 million
2023-06-30 -15.0 million 2.1 million
2023-03-31 -15.0 million 2.1 million
2022-12-31 -9.8 million 2.3 million

NXTC Net Income

No data available :(

NXTC Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 118.2 million - 6.1 million
2023-06-30 130.6 million - 6.3 million
2023-03-31 145.5 million - 6.5 million
2022-12-31 159.9 million - 7.1 million

NXTC Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 27.8 million
2023-06-30 27.8 million
2023-03-31 27.8 million
2022-12-31 27.7 million

NXTC Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 279000 11.0 million 4.6 million -
2023-06-30 280000 13.4 million 5.7 million -
2023-03-31 248000 11.6 million 5.4 million -
2022-12-31 865000 12.8 million 4.9 million -

NXTC Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 946000
2023-06-30 - 1.1 million
2023-03-31 - 1.1 million
2022-12-31 - 1.4 million

NXTC

Price: $1.30

52 week price:
0.98
2.57

Earnings Per Share: -2.25 USD

P/E Ratio: -0.56

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 224200

Market Capitalization: 60.8 million

Links: